Use of Molecular Imaging Markers of Glycolysis, Hypoxia and Proliferation (18F-FDG, 64Cu-ATSM and 18F-FLT) in a Dog with Fibrosarcoma: The Importance of Individualized Treatment Planning and Monitoring

Kamilla Zornhagen, Malene Clausen, Anders Elias Hansen, Ian Law, Fintan McEvoy, Svend Engelholm, Andreas Kjær, Annemarie Kristensen

    Research output: Contribution to journalJournal articleResearchpeer-review

    267 Downloads (Pure)

    Abstract

    Glycolysis, hypoxia, and proliferation are important factors in the tumor microenvironment contributing to treatment-resistant aggressiveness. Imaging these factors using combined functional positron emission tomography and computed tomography can potentially guide diagnosis and management of cancer patients. A dog with fibrosarcoma was imaged using 18F-FDG, 64Cu-ATSM, and 18F-FLT before, during, and after 10 fractions of 4.5 Gy radiotherapy. Uptake of all tracers decreased during treatment. Fluctuations in 18F-FDG and 18F-FLT PET uptakes and a heterogeneous spatial distribution of the three tracers were seen. Tracer distributions partially overlapped. It appears that each tracer provides distinct information about tumor heterogeneity and treatment response.
    Original languageEnglish
    JournalDiagnostics
    Volume5
    Issue number3
    Pages (from-to)372-382
    Number of pages11
    ISSN2075-4418
    DOIs
    Publication statusPublished - 2015

    Bibliographical note

    © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).

    Cite this